| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |